DOCSLIB.ORG

Toxicological Profile for Trichloroethylene

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Toxicological Profile for Trichloroethylene SDMS DOCID# 1112586 TOXICOLOGICAL PROFILE FOR TRICHLOROETHYLENE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 1997 TRICHLOROETHYLENE ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. TRICHLOROETHYLENE iii UPDATE STATEMENT An update Toxicological Profile for Trichloroethylene was released in April 1993. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary, but no less than once every three years. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, E-29 Atlanta, Georgia 30333 *Legislative Background vi The toxicological profiles are developed in response to the Super-fund Amendments and Reauthorization Act (SARA) of 1986 (Public Law 99-499) which amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund). This public law directed ATSDR to prepare toxicological profiles for hazardous substances most commonly found at facilities on the CERCLA National Priorities List and that pose the most significant potential threat to human health, as determined by ATSDR and the EPA. The availability of the revised priority list of 275 hazardous substances was announced in the Federal Register on April 29, 1996 (61 FR 18744). For prior versions of the list of substances, see Federal Register notices dated April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR 43619); October 17,1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801); and February 28, 1994 (59 FR 9486). Section 104(i)(3) of CERCLA, as amended, directs the Administrator of ATSDR to prepare a toxicological profile for each substance on the list. TRICHLOROETHYLENE vii CONTRIBUTORS CHEMICAL MANAGER(S)/AUTHOR(S): Mildred Williams-Johnson, Ph.D., D.A.B.T. ATSDR, Division of Toxicology, Atlanta, GA Carol J. Eisenmann, Ph.D. Sciences International, Inc., Alexandria, VA Steven G. Donkin, Ph.D. Sciences International, Inc., Alexandria, VA The Chemical Manager and Authors acknowledge the contribution of Dr. Ted W. Simon, U.S. EPA, in applying physiologically-based pharmacokinetic modeling to the development of minimal risk levels for trichloroethylene. THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS: 1. Green Border Review. Green Border review assures consistency with ATSDR policy. 2. Health Effects Review. The Health Effects Review Committee examines the health effects chapter of each profile for consistency and accuracy in interpreting health effects and classifying end points. 3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to substance-specific minimal risk levels (MRLs), reviews the health effects database of each profile, and makes recommendations for derivation of MRLs. TRICHLOROETHYLENE ix PEER REVIEW A peer review panel was assembled for trichloroethylene. The panel consisted of the following members: 1. Herbert Cornish, Ph.D., Private Consultant, Ypsilanti, MI 2. James Klaunig, Ph.D., Indiana University School of Medicine, Indianapolis, IN 3. Norbert Page, Ph.D., Private Consultant, Gaithersburg, MD These experts collectively have knowledge of trichloroethylene’s physical and chemical properties, toxico- kinetics, key health end points, mechanisms of action, human and animal exposure, and quantification of risk to humans. All reviewers were selected in conformity with the conditions for peer review specified in Section 104(i)( 13) of the Comprehensive Environmental Response, Compensation, and Liability Act, as amended. Scientists from the Agency for Toxic Substances and Disease Registry (ATSDR) have reviewed the peer reviewers’ comments and determined which comments will be included in the profile. A listing of the peer reviewers’ comments not incorporated in the profile, with a brief explanation of the rationale for their exclusion, exists as part of the administrative record for this compound. A list of databases reviewed and a list of unpublished documents cited are also included in the administrative record. The citation of the peer review panel should not be understood to imply its approval of the profile’s final content. The responsibility for the content of this profile lies with the ATSDR. TRICHLOROETHYLENE 1 1. PUBLIC HEALTH STATEMENT This public health statement tells you about trichloroethylene and the effects of exposure. The Environmental Protection Agency (EPA) has identified 1,428 hazardous waste sites as the most serious in the nation. These sites make up the National Priorities List (NPL) and are targeted for long-term federal clean-up. Trichloroethylene has been found in at least 861 NPL sites. However, it’s unknown how many NPL sites have been evaluated for this substance. As EPA looks at more sites, the sites with trichloroethylene may increase. This is important because exposure to this substance may harm you and because these sites may be sources of exposure. When a substance is released from a large area, such as an industrial plant, or from a container, such as a drum or bottle, it enters the environment. This release does not always lead to exposure. You are exposed to a substance only when you come in contact with it by breathing, eating, touching, or drinking. If you are exposed to trichloroethylene, many factors will determine whether you’ll be harmed. These factors include the dose (how much), the duration (how long), and how you come in contact with it. You must also consider the other chemicals you’re exposed to and your age, sex, diet, family traits, lifestyle, and state of health. 1.1 WHAT IS TRICHLOROETHYLENE? Trichloroethylene is also known as Triclene and Vitran and by other trade names in industry. It is a nonflammable, colorless liquid at room temperature with a somewhat sweet odor and a sweet, burning taste. Trichloroethylene is now mainly used as a solvent to remove grease from metal parts. It is also used as a solvent in other ways and is used to make other chemicals. Trichloroethylene can also be found in some household products, including typewriter correction fluid, paint removers, adhesives, and spot removers. Most people can begin to smell trichloroethylene in air when there are around 100 parts of trichloroethylene per million parts of air (ppm). Further information on the physical and chemical properties of trichloroethylene can be found in Chapter 3, and further information on its production and use can be found in Chapter 4. TRICHLOROETHYLENE 2 1. PUBLIC HEALTH STATEMENT 1.2 WHAT HAPPENS TO TRICHLOROETHYLENE WHEN IT ENTERS THE ENVIRONMENT? By far, the biggest source of trichloroethylene in the environment is evaporation from factories that use it to remove grease from metals. It can also enter the air and water when it is disposed of at chemical waste sites. It evaporates easily but can stay in the soil and in groundwater. Once it is in the air, about half will be broken down within a week. When trichloroethylene is broken down in the air, phosgene, a lung irritant, can be formed. Trichloroethylene can break down under high heat and alkaline conditions to form dichloroacetylene and phosgene. In the body, trichloroethylene may break down into dichloroacetic acid (DCA), trichloroacetic acid (TCA), chloral hydrate, and 2-chloroacetaldehyde. These products have been shown to be toxic to animals and are probably toxic to humans. Once trichloroethylene is in water, much will evaporate into the air; again, about half will break down within a week. It will take days to weeks to break down in surface water. In groundwater the breakdown is much slower because of the much slower evaporation rate. Very little trichloroethylene breaks down in the soil, and it can pass through the soil into underground water. It is found in some foods. The trichloroethylene found in foods is believed to come from contamination of the water used in food processing, or from food processing equipment cleaned with trichloroethylene. It does not build up in fish, but low levels have been found in them. It is not likely to build up in your body. For more information on trichloroethylene in the environment, see Chapters 4 and 5. 1.3 HOW MIGHT I BE EXPOSED TO TRICHLOROETHYLENE? Trichloroethylene is found in the outdoor air at levels far less than 1 ppm. When measured several years ago, some of the water supplies in the United States were found to have tuichloroethylene. The most recent monitoring study found average levels in surface water ranging from 0.0001 to 0.001 ppm of water and an average level of 0.007 ppm in groundwater. About 400,000 workers are routinely exposed to trichloroethylene in the United States. The chemical can also get into the air or water in many ways, for example, at waste treatment facilities; by evaporation from paints, glues, and other products; or by release from factories where it is made. Another way you may be exposed is by breathing the air around factories that use the chemical. People living near hazardous waste sites may be exposed to it in the air or in TRICHLOROETHYLENE 3 1. PUBLIC HEALTH STATEMENT their drinking water, or in the water used for bathing or cooking. Products that may contain trichloroethylene are some types of typewriter correction fluids, paints and paint removers, glues, spot removers, rug cleaning fluids, and metal cleaners. For more information on exposure to trichloroethylene, see Chapter 5. 1.4 HOW CAN TRICHLOROETHYLENE ENTER AND LEAVE MY BODY? Trichloroethylene enters your body when you breathe air or drink water containing it. It can also enter your body if you get it on your skin. You could be exposed to contaminated water or air if you live near or work in a factory that uses trichloroethylene or if you live near a waste disposal site that contains trichloroethylene.
Load more

Recommended publications
  • This Table of Gas and Materials Compatibility
    Materials Compatibility Section G – Technical Data Section G – Technical Gas Compatibility Directions The compatibility data shown on pages To use the compatibility chart on the 2 and 3 of this Section G have been following pages, proceed as follows: compiled to assist in evaluating ap- 1 3 propriate materials for use in handling various gases. It is extremely important Locate the gas you are using in the Refer to the applicable “Key to that all gas control equipment be com- first column of the chart. Materials Compatibility Symbol”. patible with the gas being used. The 2 4 use of a device that is not compatible Check the materials of construction Verify that the “Key to Materials may damage the unit and cause a leak you intend to use. Materials of Compatibility Symbol” allows this that could result in property damage Construction have been grouped by combination and that the application or personal injury. To reduce potentially metals, plastics and elastomers. is satisfactory. harmful situations, always check for the compatibility of equipment and materials before using any gases in Key to Materials Compatibility your gas control equipment. S – Satisfactory for use with the intended gas. Since combinations of gases are C – Conditional. May be incompatible under some circumstances or conditions. virtually unlimited, mixtures (except Contact your Praxair representative for additional information. for Oxyfume® and Medifume® steril- U – Unsatisfactory for use with the intended gas. izing gas mixtures) are not listed in the Compatibility Chart. Before using a I – Insufficient data available to determine compatibility with the gas mixture or any gas not listed in the intended gas.
    [Show full text]
  • Rhode Island Hazardous Substance List
    Rhode Island Hazardous Substance List Source: T - ACGIH F - NFPA49 C - IARC Alphabetical Order C.A.S. ACGIH NFPA IARC CHEMICAL NAME 13010-47-4 C 1,-(2-Chloroethyl)-3-cyclohexyl-1-Nitrosourea 76-11-9 T 1,1,1,2-tetrachloro-2,2-difluoroethane 76-12-0 T 1,1,2,2-tetrachloro-1,2-difluoroethane 79-34-5 T 1,1,2,2-tetrachloroethane - skin 76-13-1 T 1,1,2-trichloro-1,2,2-trifluoroethane 79-00-5 T F C 1,1,2-trichloroethane - skin 594-72-9 T 1,1-Dichloro-1-nitroethane 74-34-3 T 1,1-dichloroethane 57-14-7 T 1,1-dimethylhydrazine (udmh) 96-18-4 T 1,2,3-trichloropropane 120-82-1 T 1,2,4-Trichlorobenzene 106-88-7 F 1,2-Butylene oxide 107-15-3 T F 1,2-Diaminoethane 96-12-8 C 1,2-Dibromo-3-chloropropane 106-93-4 T F C 1,2-Dibromoethane - skin 107-06-2 T F 1,2-Dichlorethane 540-59-0 T F 1,2-Dichloroethene 540-59-0 T F 1,2-Dichloroetylene 1615-80-1 C 1,2-Diethylhydrazine C 1,2-Dimethyl hydrazine - skin 106-99-0 T F 1,3-Butadiene 118-52-5 T 1,3-Dichloro-5,5-dimethylhydantoin 542-75-6 T F 1,3-Dichloropropene (cis and trans) 542-75-6 T F 1,3-Dichloropropylene 110-56-5 F 1,4-Dichlorobutane 123-91-1 T F C 1,4-Dioxane 1120-71-4 1-3-Propane sultone 110-53-2 F 1-Bromopentane 106-89-8 T F C 1-Chloro,2,3-epoxy-propane 600-25-9 T 1-Chloro-1-nitropropane 97-00-7 F 1-chloro-2,4-dinitrobenzene 543-59-9 F 1-Chloropentane 112-30-1 F 1-Decanol 111-27-3 F 1-Hexanol 141-79-7 T F 1-Isobutenyl methyl ketone 108-03-2 T F 1-Nitropropane 71-41-0 F 1-Pentanol 110-58-7 F 1-Pentylamine 111-40-0 T F 2,2'-Diaminodiethylamine 111-44-4 F 2,2'Dichlorodiethyl ether 75-99-0 T 2,2-dichloropropionic acid 556-52-5 T 2,3-Epoxy-1-propanol 93-76-5 T 2,4,5-T 95-95-4 F 2,4,5-trichlorophenol 88-06-2 F C 2,4,6-trichlorophenol 118-96-7 T F 2,4,6-Trinitro Toluene 479-95-8 T 2,4,6-Trinitrophenyl-methylnitramine 94-75-7 T 2,4-d (2,4-dichlorophenoxyacetic acid) 97-02-9 F 2,4-dinitroaniline 584-84-9 T F 2,4-Tolylene diisocyanate 108-83-8 T 2,6-Dimethyl-4-heptanone 108-83-8 T 2,6-Dimethyl-4-heptanone 128-37-0 T 2,6-Ditert.
    [Show full text]
  • Zinc, Magnesium and NMDA Receptor Alterations in the Hippocampus of Suicide Victims
    Journal of Affective Disorders 151 (2013) 924–931 Contents lists available at ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims Magdalena Sowa-Kućma a,n, Bernadeta Szewczyk a, Krystyna Sadlik b, Wojciech Piekoszewski c,d, Franciszek Trela e,Włodzimierz Opoka f, Ewa Poleszak g, Andrzej Pilc a,h, Gabriel Nowak a,i a Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland b Institute of Forensic Research, Kraków, Poland c Department of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University, Kraków, Poland d Laboratory of High Resolution Mass Spectrometry, Regional Laboratory of Physicochemical Analysis and Structural Research, Faculty of Chemistry, Jagiellonian University, Kraków, Poland e Department of Forensic Medicine, Jagiellonian University Medical College, Kraków, Poland f Department of Inorganic Chemistry, Jagiellonian University Medical College, Kraków, Poland g Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland h Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland i Chair of Pharmacobiology, Jagiellonian University Medical College, Kraków, Poland article info abstract Article history: Background: There is evidence for an association between suicidal behavior and depression. Accumulat- Received 27 May 2013 ing data suggests that depression is related to a dysfunction of the brain's glutamatergic system, and that Received in revised form the N-methyl-D-aspartate (NMDA) receptor plays an important role in antidepressant activity. Zinc and 9 August 2013 magnesium, the potent antagonists of the NMDA receptor complex, are involved in the pathophysiology Accepted 9 August 2013 of depression and exhibit antidepressant activity.
    [Show full text]
  • Zinc-Magnesium Supplementation, Hormones and Strength
    Zinc-Magnesium Supplementation, Hormones and Strength JEPonline Journal of Exercise Physiologyonline Official Journal of The American Society of Exercise Physiologists (ASEP) ISSN 1097-9751 An International Electronic Journal Volume 3 Number 4 October 2000 Exercise Nutrition Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength L.R. BRILLA1 AND VICTOR CONTE2 1Exercise and Sports Science Laboratory, Western Washington University, Bellingham, WA 98225-9067 and 2BALCO Laboratories, 1520 Gilbreth Road, Burlingame, CA 94010, Tel: 800-777-7122 L.R. BRILLA AND VICTOR CONTE. Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength. JEPonline, 3(4): 26-36, 2000. Muscle attributes and selected blood hormones of football players were assessed in response to a nightly supplementation regimen during spring football, over an 8-week period, with pre-post measures. A double-blind randomized study was conducted with ZMA (30 mg zinc monomethionine aspartate, 450 mg magnesium aspartate, and 10.5 mg of vitamin B-6) and placebo (P), n=12 and n=15, respectively. Plasma zinc and magnesium levels were ZMA (0.80 to 1.04 mg/ml; 19.43 to 20.63 mcg/ml ) and P (0.84 to 0.80 mg/ml ; 19.68 to 18.04 mg/ml), respectively (P<0.001). Free testosterone increased with ZMA (132.1 to 176.3 pg/mL), compared to P (141.0 to 126.6 pg/mL) (P<0.001); IGF-I increased in the ZMA group (424.2 to 439.3 ng/mL) and decreased in P (437.3 to 343.3 ng/mL) (P<0.001).
    [Show full text]
  • Photocatalytic Bleaching of Evans Blue Over Zinc Oxide Particulate
    Indian Journal of Chemistry Vol. 46A, March 2007, pp. 432-435 8 Photocatalytic bleaching of Evans blue over Matsuo and Udea have used SrTiO3-TiO2 composite zinc oxide particulate system powder for the photocatalytic bleaching of methylene blue. Preparation and characterization of ZnO/TiO2, Sharad Kothari*, Preeti Ameta & Rameshwar Ameta photocatalyst and their photocatalytic activity were reported by Liao et al.9 PG Department of Chemistry, Government College, 10,11 Banswara 327 001, India Sehili et al. have investigated the photocatalytic Email: [email protected] transformation of chloroaromatic derivatives such as Received 10 May 2006; revised 31 January 2007 chlorophenol and dichlorobenzenes on ZnO involving the formation of an adduct between OH• radicals and Evans blue, an azo dye, and its mixture with amaranth are 12 degraded photocatalytically in presence of zinc oxide. The aromatic compound. Driessen et al. have studied optimum conditions for photobleaching of these dyes, like surface band(CB) and gas phase products and concentration of dye, pH, amount of semiconductor, light intermediates with FT-IR spectroscopy during intensity, etc., have been studied. During the photocatalytic photocatalytic oxidation of trichloroethylene on ZnO. degradation, the semiconductor (ZnO) remains unaffected as Synthesis and photocatalytic activity of ZnO/ZrO2 evident from its FT-IR. The studied dyes are commonly used in 13 dyeing, printing and textile industries and hence, the present work composite have been reported by Hsu and Wu. Riaj will be helpful in the treatment of coloured effluents from these et al.14 used ZnO as a photocatalyst for the industries. photocatalytic bleaching of rhodamine-6G. 8 Photocatalytic bleaching of Evan blue (EB) has not IPC Code: Int.
    [Show full text]
  • Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit
    molecules Review Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit/Hyperactivity Disorder (ADHD) Harry Robberecht *, Annelies A. J. Verlaet, Annelies Breynaert, Tess De Bruyne and Nina Hermans Laboratory of Nutrition and Functional Food Science, NatuRA (Natural Products and Food Research and Analysis), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium; [email protected] (A.A.J.V.); [email protected] (A.B.); [email protected] (T.D.B.); [email protected] (N.H.) * Correspondence: [email protected]; Tel.: +00-32-3265-2706 Academic Editors: Alejandro Samhan-Arias and Valeria M. Nurchi Received: 8 July 2020; Accepted: 25 September 2020; Published: 27 September 2020 Abstract: In this study, we critically review the literature concerning the relation of Mg, Fe, Zn, Cu and Se and attention-deficit/hyperactivity disorder (ADHD). Elemental status is estimated using peripheral blood parameters, hair, urine, daily intake and response to supplementation. The observed associations between concentration levels of the elements Mg, Fe, Zn, Cu and Se and ADHD symptoms are contradictory. This is partly due to the heterogeneity and complexity of the disorder. As a trend, lower ferritin and zinc levels can be observed. However, this correlation is not causative, as illustrated by placebo-controlled trials reporting conflicting evidence on the efficacy of supplementation. Well-defined studies on changes in concentration levels of the elements in relation to ADHD symptoms before and after treatment with therapeutics it will be possible to shed more light on the significance of these elements in this behavioral disorder. The discussion on whether a change in concentration of an element is cause or consequence of ADHD is not within the scope of this article.
    [Show full text]
  • The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies
    International Journal of Molecular Sciences Article The Interaction of Selective A1 and A2A Adenosine Receptor Antagonists with Magnesium and Zinc Ions in Mice: Behavioural, Biochemical and Molecular Studies Aleksandra Szopa 1,* , Karolina Bogatko 1, Mariola Herbet 2 , Anna Serefko 1 , Marta Ostrowska 2 , Sylwia Wo´sko 1, Katarzyna Swi´ ˛ader 3, Bernadeta Szewczyk 4, Aleksandra Wla´z 5, Piotr Skałecki 6, Andrzej Wróbel 7 , Sławomir Mandziuk 8, Aleksandra Pochodyła 3, Anna Kudela 2, Jarosław Dudka 2, Maria Radziwo ´n-Zaleska 9, Piotr Wla´z 10 and Ewa Poleszak 1,* 1 Chair and Department of Applied and Social Pharmacy, Laboratory of Preclinical Testing, Medical University of Lublin, 1 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (K.B.); [email protected] (A.S.); [email protected] (S.W.) 2 Chair and Department of Toxicology, Medical University of Lublin, 8 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (M.H.); [email protected] (M.O.); [email protected] (A.K.) [email protected] (J.D.) 3 Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, 1 Chod´zkiStreet, PL 20–093 Lublin, Poland; [email protected] (K.S.);´ [email protected] (A.P.) 4 Department of Neurobiology, Polish Academy of Sciences, Maj Institute of Pharmacology, 12 Sm˛etnaStreet, PL 31–343 Kraków, Poland; [email protected] 5 Department of Pathophysiology, Medical University of Lublin, 8 Jaczewskiego Street, PL 20–090 Lublin, Poland; [email protected] Citation: Szopa, A.; Bogatko, K.; 6 Department of Commodity Science and Processing of Raw Animal Materials, University of Life Sciences, Herbet, M.; Serefko, A.; Ostrowska, 13 Akademicka Street, PL 20–950 Lublin, Poland; [email protected] M.; Wo´sko,S.; Swi´ ˛ader, K.; Szewczyk, 7 Second Department of Gynecology, 8 Jaczewskiego Street, PL 20–090 Lublin, Poland; B.; Wla´z,A.; Skałecki, P.; et al.
    [Show full text]
  • 160 'Ideal' Gases: Anaesthetics in the Heart of the Twentieth Century Ian
    International Workshop on the History of Chemistry 2015 Tokyo ‘Ideal’ Gases: Anaesthetics in the Heart of the Twentieth Century Ian D. Rae University of Melbourne, Australia 1. Introduction By 1920 only three gaseous anaesthetics were widely used – nitrous oxide, diethyl ether (ether) and chloroform. The toxicity of chloroform was acknowledged, nitrous oxide did not induce deep anaesthesia, and ether was extremely inflammable, so in the 1920s there were good reasons to search for new anaesthetics. While my concern is with gaseous anaesthetics, I recognise that there were parallel developments in two related fields, that of topical or local anaesthetics, typified by the natural product cocaine and a host of synthetic substances, and injectable anaesthetics starting with opiates, then barbiturates and leading to modern materials such as propofol (2,6-diisopropylphenol). 2. Theories of anaesthetic action Hans Meyer1 noted that the anaesthetic substances were soluble in both fatty and aqueous media, proposed a general theory of anaesthesia based on the partition or distribution coefficient as a critical determinant. Meyer enunciated the following three principles that underpinned his theory: all chemically inert substances that are soluble in fats and fatty materials will produce narcosis; the line of action is in the nerve cells; the comparative strengths of substances depend on their solubility in fatty material and in water, that is, on the distribution coefficient. Charles Overton arrived at the same idea independently. Some years after completing his PhD research on cell permeability studies, Overton first presented his theory of narcosis in a lecture to the Society for Natural History in Zurich in October 1898, in a paper published the following year2 and in his book3 which included a full exposition.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0059270 A1 Hall Et Al
    US 2007005927OA1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0059270 A1 Hall et al. (43) Pub. Date: Mar. 15, 2007 (54) ION EXCHANGE RESIN TREATED TO (22) Filed: Sep. 13, 2005 CONTROL, SWELLING Publication Classification (75) Inventors: Harlan Hall, Oregon, WI (US); J. Scott Madsen, Cottage Grove, WI (US) (51) Int. Cl. A 6LX 3L/795 (2006.01) Correspondence Address: (52) U.S. Cl. ............................................................ 424/78.1 CHALKER FLORES, LLP 2711 LBJ FRWY (57) ABSTRACT Suite 1036 DALLAS, TX 75234 (US) The present invention provides a method and composition are provided that includes an ion exchange resin treated with (73) Assignee: The Coating Place, Inc., Verona, WI from between about 0.01 to about 10 percent by weight of one or more Sugar alcohols in contact with one or more ionic (21) Appl. No.: 11/225,834 pharmaceutically active drug. US 2007/0059270 A1 Mar. 15, 2007 ON EXCHANGE RESIN TREATED TO CONTROL drug bound to an ion-exchange resin to provide a drug-resin SWELLING complex having a drug content above a specified value. The drug-resin complex is Subsequently coated with a water TECHNICAL FIELD OF THE INVENTION permeable diffusion barrier coating that is insoluble in 0001. The present invention relates general to the con gastrointestinal fluids. Thus, the release of drug is controlled trolled release of active agents, and in particular, to phar under conditions encountered in the gastrointestinal tract. macologically active drugs adsorbed to ion exchange resin. 0007 One of the major disadvantages with the use of an ion exchange resin as a pharmaceutical delivery agent is that BACKGROUND OF THE INVENTION ion exchange resin particles are Susceptible to Swelling.
    [Show full text]
  • PREPARATION of C-Tio2 NANOPHOTOCATALYST and ITS USED for DEGRADATION of EVANS BLUE
    Sci. Revs. Chem. Commun.: 6(1), 2016, 12-18 ISSN 2277-2669 PREPARATION OF C-TiO2 NANOPHOTOCATALYST AND ITS USED FOR DEGRADATION OF EVANS BLUE PREETI S. PILLAIa, DINESH I. PRAJAPATIb, RAKSHIT AMETAa and YASMIN ALI* Department of Chemistry, Techno-NJR Institute of Technology, UAIPUR (Raj) INDIA aDepartment of Chemistry, PAHER University, UDAIPUR (Raj.) INDIA bDepartment of Chemistry, M. G. Science Institute, AHMEDABAD (Guj.) INDIA (Received : 08.03.2016; Accepted : 20.03.2016) ABSTRACT The present work incorporates the study of efficiency of carbon doped TiO2 for photocatalytic degradation of Evans blue dye. Effect of some factors such as catalyst dose, concentration of dye, intensity of light, pH etc., on degradation of the dye was examined. The reaction followed pseudo first order kinetics. Participation of •OH free radical was confirmed by scavenger studies. Optimum conditions were determined by variation of operational parameters. A tentative mechanism for photocatalytic degradation of Evans Blue has been proposed. Key words: Carbon doped TiO2, Photocatalytic degradation, Evans blue dye. INTRODUCTION Water pollution is increasing day by day, which attracted the attention of many resercheres on this subject. Out of various technique used for the removal of toxic substance, photocatalytic method has emerged as most effective and promising technique. Photcatalytic degradation of basic blue –24 and orange- G over ZnO powder in the presence of surfactant was been reported by Ameta et al.1 Rao et al.2 observed the photocatalytic degradation of crystal violet in aqueous suspension of zinc oxide. Papadam et al.3 worked on photocatalytic converstion of acid orange 20 and Cr (VI) in aqueous TiO2.
    [Show full text]
  • The Effects of Combined Magnesium and Zinc Supplementation On
    Hamedifard et al. Lipids in Health and Disease (2020) 19:112 https://doi.org/10.1186/s12944-020-01298-4 RESEARCH Open Access The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease Zahra Hamedifard1, Alireza Farrokhian2, Željko Reiner3, Fereshteh Bahmani1, Zatollah Asemi1, Maryam Ghotbi1 and Mohsen Taghizadeh1* Abstract Background: The present research aimed to analyze the impacts of magnesium and zinc supplements on glycemic control, serum lipids, and biomarkers of oxidative stress and inflammation in patients suffering from coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Methods: According to the research design, a randomized, double-blind, placebo-controlled trial has been implemented on 60 subjects suffering from CHD and T2DM. Therefore, participants have been randomly divided into 2 groups for taking placebo (n = 30) or 250 mg magnesium oxide plus 150 mg zinc sulfate (n = 30) for 12 weeks. Results: Magnesium and zinc significantly decreased fasting plasma glucose (FPG) (β − 9.44 mg/dL, 95% CI, − 18.30, − 0.57; P = 0.03) and insulin levels (β − 1.37 μIU/mL, 95% CI, − 2.57, − 0.18; P = 0.02). Moreover, HDL-cholesterol levels significantly enhanced (β 2.09 mg/dL, 95% CI, 0.05, 4.13; P = 0.04) in comparison to the placebo. There was an association between magnesium and zinc intake, and a significant decrease of C-reactive protein (CRP) (β − 0.85 mg/L, 95% CI, − 1.26, − 0.45; P < 0.001), a significant increase in total nitrite (β 5.13 μmol/L, 95% CI, 1.85, 8.41; P =0.003)and total antioxidant capacity (TAC) (β 43.44 mmol/L, 95% CI, 3.39, 83.50; P = 0.03) when compared with placebo.
    [Show full text]
  • The Absorption and Retention of Magnesium, Zinc, and Copper by Low Birth Weight Infants Fed Pasteurized Human Breast Milk
    Pediat. Res. 11: 991-997 (1977) Absorption magnesium copper newborn low birth weight infants zinc The Absorption and Retention of Magnesium, Zinc, and Copper by Low Birth Weight Infants Fed pasteurized Human Breast Milk M. J. DAUNCEY, J. C. L. SHAW,'3" AND J. URMAN Depnrttnent of Poedintrics, University College Hospitnl, Londorz, and Medical Resenrcll Council Dicnn Nutrition Unit, Cilmbridge, England Summary about two-thirds of the magnesium and perhaps one-third of the zinc in the body are present in the bones. Because of the " Using serial metabolic balance techniques, the absorption and extensive remodeling of fetal bone after birth retention of magnesium, copper, and zinc have been measured much of the magnesium and zinc in bone, as well as the hepatic in six preterm infants (mean gestation 29 weeks), and two term copper, probably become available to meet the later needs of the , small for gestational age infants (<1.5 kg birth weight). The growing full term infant. amounts of the minerals retained were compared with the The infant born months prematurely, however, has much amounts retained by a fetus of equivalent ~e~~~~~~~~lage in smaller amounts of magnesium, copper, and zinc in his body, u tero . and must rely on the fetal intestine to absorb enough of these The preterm absorbed 5'3 * 3'5 mg/kg'day "lagne- substances for his needs. Cavell and Widdowson (4) showed that sium (43% of intake, range 1-74%) and retained 2.8 * 1.3 mg/ full term infants were in negative balance for copper and zinc in kg' (25% intake, range -I5 to +48%)' The mean postna- the newborn period, and the reports of Tkacenko (21) and of tal retention over the period, as a percentage of Widdowson et a/.
    [Show full text]